πŸ‡ΊπŸ‡Έ FDA
Patent

US 10918691

Modulators of complement activity

granted A61KA61K38/10A61K39/00

Quick answer

US patent 10918691 (Modulators of complement activity) held by RA PHARMACEUTICALS, INC. expires Mon Feb 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
RA PHARMACEUTICALS, INC.
Grant date
Tue Feb 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K38/10, A61K39/00, A61P, A61P25/00